These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20663072)

  • 1. Iterative cardiac output measurement for optimizing cardiac resynchronization therapy: a randomized, blinded, crossover study.
    Reinsch N; Konorza T; Woydowski D; Bruck H; Volsek M; Müller-Tasch T; Neumann T; Erbel R; Wieneke H
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1188-94. PubMed ID: 20663072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we optimize cardiac resynchronization therapy during exercise?
    Bogaard MD; Kirkels JH; Hauer RN; Loh P; Doevendans PA; Meine M
    J Cardiovasc Electrophysiol; 2010 Nov; 21(11):1307-16. PubMed ID: 20550613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
    Ellenbogen KA; Gold MR; Meyer TE; Fernndez Lozano I; Mittal S; Waggoner AD; Lemke B; Singh JP; Spinale FG; Van Eyk JE; Whitehill J; Weiner S; Bedi M; Rapkin J; Stein KM
    Circulation; 2010 Dec; 122(25):2660-8. PubMed ID: 21098426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy optimization using noninvasive cardiac output measurement.
    Khan FZ; Virdee MS; Hutchinson J; Smith B; Pugh PJ; Read PA; Fynn SP; Dutka DP
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1527-36. PubMed ID: 21797899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimisation of atrioventricular delay during exercise improves cardiac output in patients stabilised with cardiac resynchronisation therapy.
    Sun JP; Lee AP; Grimm RA; Hung MJ; Yang XS; Delurgio D; Leon AR; Merlino JD; Yu CM
    Heart; 2012 Jan; 98(1):54-9. PubMed ID: 21880650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic investigation into how long-term resynchronization therapy confers ongoing cardiac functional benefits and improved exercise capacity.
    Schlosshan D; Barker D; Lewis N; Pepper C; Tan LB
    Am J Cardiol; 2009 Mar; 103(5):701-8. PubMed ID: 19231337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor.
    Ståhlberg M; Kessels R; Linde C; Braunschweig F
    Europace; 2011 Feb; 13(2):237-43. PubMed ID: 20952424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrioventricular delay programming in cardiac resynchronization therapy devices: fixed or adaptive? A randomized monocenter trial.
    Schueler M; Voss F; Bauer A; Thomas D; Kelemen K; Katus HA; Becker R
    J Electrocardiol; 2012; 45(6):783-6. PubMed ID: 22727475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing atrioventricular and interventricular intervals following cardiac resynchronization therapy.
    Nayar V; Khan FZ; Pugh PJ
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):185-97. PubMed ID: 21453215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the atrioventricular delay during cardiac resynchronization therapy using a device for non-invasive measurement of cardiac index at rest and during exercise.
    Prochnau D; Forberg T; Kühnert H; Heinke M; Figulla HR; Surber R
    Europace; 2012 Feb; 14(2):249-53. PubMed ID: 21933798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive cardiac output measurements based on bioreactance for optimization of atrio- and interventricular delays.
    Khan FZ; Virdee MS; Pugh PJ; Read PA; Fynn SP; Dutka DP
    Europace; 2009 Dec; 11(12):1666-74. PubMed ID: 19910316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Advantage of optimizing V-V timing in cardiac resynchronization therapy devices" by Dr. Duvall.
    Geng J; Zhu J
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1289-90; author reply 1290-1. PubMed ID: 20718923
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrogram-based optimal atrioventricular and interventricular delays of cardiac resynchronization change individually during exercise.
    Golovchiner G; Dorian P; Mangat I; Korley V; Ahmad K; Sharef K; Posan E; Crystal E; O'Donnell S; Pinter A
    Can J Cardiol; 2011; 27(3):351-7. PubMed ID: 21489747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P; Tulner SA; Bax JJ; Oemrawsingh PV; Bleeker GB; van Erven L; Putter H; Verwey HF; van der Wall EE; Schalij MJ
    Circulation; 2006 Mar; 113(10):1295-304. PubMed ID: 16520415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.
    León AR; Abraham WT; Brozena S; Daubert JP; Fisher WG; Gurley JC; Liang CS; Wong G;
    J Am Coll Cardiol; 2005 Dec; 46(12):2298-304. PubMed ID: 16360062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study to evaluate the efficacy of an intracardiac electrogram-based atrioventricular and interventricular intervals optimization method in cardiac resynchronization therapy.
    Hua W; Wang DM; Cai L; Sun CF; Fu GS; Wang YT; Yan J; Luo ZL; Xu J; Wang ZY; Xu G; Shen FR; Xu W; Wang JF; Ren XJ; Jin W; Zhang N; Lau EO; Zhang S
    Chin Med J (Engl); 2012 Feb; 125(3):428-33. PubMed ID: 22490397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome.
    Ajijola OA; Macklin EA; Moore SA; McCarty D; Bischoff KE; Heist EK; Picard M; Ruskin JN; Dec GW; Singh JP
    Europace; 2010 Dec; 12(12):1745-9. PubMed ID: 20852289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.
    Romeyer-Bouchard C; Da Costa A; Dauphinot V; Messier M; Bisch L; Samuel B; Lafond P; Ricci P; Isaaz K
    Eur Heart J; 2010 Jan; 31(2):203-10. PubMed ID: 19875388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy.
    Ståhlberg M; Damgaard M; Norsk P; Gabrielsen A; Sahlén A; Linde C; Braunschweig F
    Europace; 2009 Sep; 11(9):1160-7. PubMed ID: 19578177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic mapping of left ventricular resynchronization during cardiac resynchronization therapy procedures.
    Chan NY; Choy CC; Cheung KC; Lau CL; Lo YK; Chu PS; Yuen HC; Lau ST; Choi YC
    Chin Med J (Engl); 2010 Jul; 123(13):1645-51. PubMed ID: 20819622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.